Cyclic tensile stretch modulates osteogenic differentiation of adipose-derived stem cells via the BMP-2 pathway

Introduction

Mechanical forces play critical roles in the development and remodelling process of bone. As an alternative cell source for bone engineering, adipose-derived stem cells (ASCs) should be fully investigated for their responses to mechanical stress and the mechanisms responsible for osteogenic induction in response to mechanical signals.

Material and methods

We hypothesized that appropriate application of uniaxial cyclic tensile strain to ASCs could increase bone morphogenetic protein-2 (BMP-2) expression and improve osteogenesis of ASCs. To test our hypothesis, ASCs from the same flask of the same donor were subjected to tensile strain with different patterns in order to eliminate the difference of donor site and passage. After surface markers investigation, the osteo-induced ASCs were subjected to uniaxial cyclic tensile stretch with the following two loading patterns: long duration continuous pattern (6 h, 1 HZ, 2000 µɛ) and short duration consecutive pattern (17 min every day for 10 consecutive days, 1 HZ, 2000 µɛ). Then osteogenic related genes were analysed by real-time PCR.

Results

The ASCs were positive for the markers STRO-1, CD90 and CD44 and negative for CD34. Cyclic tensile strain of 6 continuous h’ duration significantly increased gene expressions of BMP-2 and Runx2, and depressed OCN mRNA expression. In contrast, mechanical loading of 17 min every day did not significantly affect gene expression of BMP-2, Runx2, OCN or ALP.

Conclusions

We indicate that ASCs may sense mechanical loading in a duration-dependent manner and cyclic tensile stretch may modulate the osteogenic differentiation of ASCs via the BMP-2 signalling pathway.     

Immunohistochemical detection of bone morphogenetic protein-2 and transforming growth factor beta-1 in tracheopathia osteochondroplastica

 Tracheopathia osteochondroplastica (TO) is an unusual condition characterized by cartilaginous or bony submucosal nodules in the tracheobronchial tree. Bone morphogenetic protein-2 (BMP-2) and transforming growth factor beta-1 (TGF-β1) are potent inducers for new bone formation. We studied the precise localization of BMP-2 and TGF-β1 in two autopsied cases of TO, using immunohistochemical methods. Positive BMP-2 immunoreactivity was detected in numerous mesenchymal cells and chondroblasts lining the nodules in the tracheal submucosa. BMP-2 was not found in mature lamellar bony nodules. TGF-β1 was not seen in mesenchymal cells, though it did appear in chondrocytes and osteocytes in the nodules. These results suggest that BMP-2 plays an important role in nodule formation and acts synergistically with TGF-β1 to promote the nodules inductive cascade in the tracheal submucosa. Received: 9 December 1996/Accepted: 10 April 1997     

BMP-4 mediates interacting signals between the neural tube and skin along the dorsal midline

Background: The neural tube and its overlying tissues (skin and mesenchyme) interact along the dorsal midline during early development. This has been previously demonstrated experimentally in chicken embryos by the fact that the dorsal neural tube transplanted ectopically induced expression of Msx 2 in the adjacent tissues. It is important to identify the molecules responsible for these interactions. Results: We observed that BMP-4, a member of the TGFβ-family, is expressed in the dorsal neural tube in a pattern closely correlated with that of Msx 2. hi order to investigate whether BMP-4 mediates the signal between the neural tube and the skin/ mesenchyme, BMP-4 was ectopically administered in ovo either by implantation of the recombinant protein or transplantation of COS cells producing BMP-4. Both manipulations resulted in ectopic induction of Msx 2 expression in the adjacent skin/mesenchyme. In addition, the activity of BMP-4 in inducing Msx 2 was counteracted by the floor plate. Conclusion: These data suggest that BMP-4 positively mediates the signals from the neural tube to the adjacent tissues and that this signal may be an essential step for the establishment of the dorsal midline structures.     

低氧条件下成骨细胞的增殖与分化

背景：低氧可通过多种途径作用于成骨细胞影响骨代谢,对骨生成、骨愈合等产生负面影响。 目的：观察低氧对体外培养大鼠成骨细胞增殖、分化的影响,并探讨其分子机制。 方法：分离培养新生Wistar大鼠颅盖骨成骨细胞,取第2代细胞分别在常氧(体积分数20%O₂)与低氧(体积分数3%O₂)条件下培养。 结果与结论：低氧组成骨细胞增殖、碱性磷酸酶活性、骨钙素水平及茜素红结节形成数量均明显低于常氧组(P < 0.05或  P < 0.01),说明缺氧条件对成骨细胞的增殖、分化及功能有抑制作用;低氧组骨形成发生蛋白2及Runx2表达低于常氧组(P < 0.05或P < 0.01),说明低氧条件下大鼠成骨细胞Runx2、骨形成发生蛋白2的表达受抑制。结果表明低氧可通过抑制大鼠成骨细胞的Runx2、骨形成发生蛋白2的表达进一步抑制成骨细胞的增殖与分化。     

Osteogenic response of human adipose-derived stem cells to BMP-6, VEGF,and combined VEGF plus BMP-6 in vitro

Exogenous addition of three factors—mesenchymal stem cells (MSCs), vascular endothelial growth factor (VEGF), and bone morphogenetic proteins (BMPs)—has proven to be more beneficial than delivery of any single factor for fracture repair in animal models. We studied the osteogenic differentiation of human adipose-derived stem cells (hADSCs) in the presence of VEGF, BMP-6, or VEGF plus BMP-6 to better understand their enhancement of osteoblastic differentiation of MSCs. The VEGF plus BMP-6 group demonstrated an additive effect on the enhancement of mineralization and expression of ALP and Msx2 genes. Unlike VEGF or BMP-6 alone, the combination of VEGF and BMP-6 significantly enhanced the expression of COL1A1, osterix, and Dlx5 genes. The data indicate that a cross-talk between VEGF and BMP-6 signaling pathways enhances osteogenic differentiation of hADSCs.     

Comparative study of osteogenic differentiation potential of mesenchymal stem cells derived from bone marrow and adipose tissue of osteoporotic female rats

Osteoporosis causes reduction of osteogenic differentiation of mesenchymal stem cells (MSCs) from bone marrow and adipose tissue. This study was designed to compare the osteogenic potential of bone marrow mesenchymal stem cells (BMMSCs) and adipose-derived stem cells (ADSCs) of ovariectomized (OVX) rats. MSC were harvested from bone marrow and inguinal fat pads of six OVX rats. The limitations of this report are that cells from different animals were pooled for the purpose of the experiments that were carried out in this study. At 7, 14 and 21?d of osteogenic differentiation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) conversion, alkaline phosphatase activity and gene expression for collagen I, osteocalcin, bone sialoprotein, osteopontin and bone morphogenetic protein-2 bone morphogenetic protein-2 (BMP-2) were analyzed. At 21?d, percentage of cells per field and percentage of mineralized nodule were analyzed. The data were subjected to analysis of variance, and the means were compared by Student–Newman–Keuls test. The cells, regardless of group, showed phenotypic characteristics consistent with stem cells. MTT conversion, alkaline phosphatase activity, percentage of mineralized nodule and expression of collagen I, osteocalcin and BMP-2 of ADSCs from OVX rats were higher when compared to BMMSCs from OVX rats in at least one of the evaluated periods (p?p?相似文献   

BMP-4 increases activin A gene expression during osteogenic differentiation of mouse embryonic stem cells

Abstract

Activin A is a growth factor released by mature osteoblasts that has a critical effect on bone formation. We investigated the effect of bone morphogenetic protein (BMP)-4 on activin A gene expression during in vitro osteogenic differentiation of mouse embryonic stem (ES) cells. Embryoid bodies were cultured in retinoic acid (RA) for three days and then without RA for two days. Seeded cells received osteogenic medium with β-glycerophosphate, L-ascorbic acid 2-phosphate and dexamethasone during 19 days, with or without BMP-4. Six independent experiments were carried out. Real-time PCR was used to detect gene expression of activin A, Oct-4, Nanog, osteocalcin, RUNX2 and bone alkaline phosphatase. Immunofluorescence was used to co-localize activin A with the undifferentiation marker stage-specific embryonic antigen 1. Cells treated with BMP-4 had an increased gene expression of activin A, osteocalcin and bone alkaline phosphatase (p?<?0.05). In conclusion, BMP-4 increases activin A gene expression during mouse ES cell differentiation into bone precursors.     

Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles

The osteoinductive growth factor, bone morphogenetic protein-2 (BMP-2), is capable of inducing de novo bone formation after implantation. A nanoparticulate (NP) system was developed for BMP-2 delivery based on NPs fabricated from bovine serum albumin (BSA) and stabilized by polyethylenimine (PEI) coating. In this study, the pharmacokinetics and osteoinductivity of BMP-2 delivered with different BSA NP formulations were determined by subcutaneous implantation in rats. A 7-day pharmacokinetics study showed that PEI coating on NPs effectively reduced the initial burst release of BMP-2 and prolonged the BMP-2 retention at implantation site. However, the uncoated BMP-2 NPs (BMP-2 loading of 1.44% w/w) were able to induce a robust ectopic bone formation, while no bone formation was found by the BMP-2 NPs coated with PEI. The toxicity of the PEI used for NP coating was determined to be the reason for lack of osteoinduction. Increasing BMP-2 loading (up to 5.76% w/w) was then employed to formulate NPs with lower PEI content; the higher BMP-2 loading was found to better promote induction of de novo bone. Our findings indicated that PEI coating on BSA NPs was effective for controlling BMP-2 release from NPs, but the toxicity of cationic PEI was a concern for the osteoinductive activity, which should be alleviated by further optimization of NP formulations.     

VEGF and BMP-6 enhance bone formation mediated by cloned mouse osteoprogenitor cells

New strategies such as combined utilization of growth factors may provide a better treatment for difficult fractures. We have demonstrated enhanced angiogenesis and osteogenesis through the actions of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-6 (BMP-6) on the osteogenic differentiation of a cloned mouse osteoprogenitor cell in vitro and ectopic bone formation in vivo. Human VEGF and BMP-6 genes expressed together produced a significant increase in alkaline phosphatase activity, expression of the RunX2 and osteocalcin genes and mineralization. Microcomputed tomographic analysis of subcutaneous implants consisting of cells transfected with VEGF and BMP-6 cDNA and delivered on a 3D poly (lactic-co-glycolic acid) scaffold confirmed the additive effects between VEGF and BMP-6. Ectopic bone formation in the VEGF plus BMP-6 group was greatest compared to that in either VEGF or BMP-6 alone. This is the first study that demonstrates osteogenesis in vitro and in vivo through the additive effects of VEGF and BMP-6.     

Efficient Bone Regeneration Induced by Bone Morphogenetic Protein-2 Released from Apatite-Coated Collagen Scaffolds

Abstract

Bone morphogenetic proteins (BMPs) are the most potent osteoinductive growth factors. Clinically utilized BMP-2 uses a type-I collagen scaffold as a carrier. Here we hypothesized that an apatite coating on a type-I collagen scaffold would prolong the BMP-2 release period and enhance bone regeneration in calvarial defects in mice. Apatite coating was achieved by incubating collagen scaffolds in simulated body fluid. BMP-2 release kinetics and bioactivity were evaluated by enzyme-linked immunosorbent assay and alkaline phosphatase activity measurement of cultured osteoblasts. Computed tomography and histomorphometry were performed eight weeks after various doses of BMP-2 were delivered to mouse calvarial defects using either non-modified or apatite-coated collagen scaffolds. Apatite-coated collagen scaffolds released 91.8 ± 11.5% of the loaded BMP-2 over 13 days in vitro, whereas non-modified collagen scaffolds released 98.3 ± 2.2% over the initial one day. The in vivo study showed that BMP-2 delivery with apatite-coated collagen scaffolds resulted in a significantly greater bone formation area and higher bone density than that with non-modified collagen scaffolds. This study suggests that simple apatite coating on collagen scaffolds can enhance the bone regeneration efficacy of BMP-2 released from collagen scaffolds.     

Tissue transglutaminase is involved in mechanical load–induced osteogenic differentiation of human ligamentum flavum cells

Mechanical load–induced osteogenic differentiation might be the key cellular event in the calcification and ossification of ligamentum flavum. The aim of this study was to investigate the influence of tissue transglutaminase (TGM2) on mechanical load–induced osteogenesis of ligamentum flavum cells. Human ligamentum flavum cells were obtained from 12 patients undergoing lumbar spine surgery. Osteogenic phenotypes of ligamentum flavum cells, such as alkaline phosphatase (ALP), Alizarin red-S stain, and gene expression of osteogenic makers were evaluated following the administration of mechanical load and BMP-2 treatment. The expression of TGM2 was evaluated by real-time PCR, Western blotting, and enzyme-linked immunosorbent assay (ELISA) analysis. Our results showed that mechanical load in combination with BMP-2 enhanced calcium deposition and ALP activity. Mechanical load significantly increased ALP and OC gene expression on day 3, whereas BMP-2 significantly increased ALP, OPN, and Runx2 on day 7. Mechanical load significantly induced TGM2 gene expression and enzyme activity in human ligamentum flavum cells. Exogenous TGM2 increased ALP and OC gene expression; while, inhibited TG activity significantly attenuated mechanical load–induced and TGM2-induced ALP activity. In summary, mechanical load–induced TGM2 expression and enzyme activity is involved in the progression of the calcification of ligamentum flavum.     

Heterodimeric Bone Morphogenetic Proteins Show Enhanced Activity In Vitro and In Vivo

Abstract

The bone morphogenetic proteins (BMPs), a subgroup of the TGF-β gene super-family, are dimeric molecules involved in the growth, differentiation and repair of a wide variety of tissues. Based on the observation that several of the BMPs co-purify when isolated from bovine bone and that a pattern of co-localization exists during mouse embryogenesis, we co-expressed various combinations of BMPs in Chinese hamster ovary cells to test for possible heterodimer formation and activity. Transient co-expression of BMP-2 with either BMP-5, BMP-6 or BMP-7, or BMP-4 transiently co-expressed with BMP-7, resulted in more BMP activity than expression of any single BMP. Stable cell lines were then made in order to purify and characterize co-expressed BMPs in more detail. Co-expression of BMP-2 with BMP-7 yielded heterodimeric BMP-2/7 with a specific activity about 20-fold higher than BMP homodimers in an in vitro alkaline phosphatase induction assay. These heterodimers were also 5- to 10-fold more potent than BMP-2 in inducing cartilage and bone in an in vivo assay. Similar results were obtained with BMP-2/6 heterodimer. These experiments demonstrate the increased potency of several BMP heterodimers relative to BMP homodimers and support the hypothesis that such heterodimeric forms are likely to have natural biological functions.     

Periodontal ligament stem/progenitor cells with protein-releasing scaffolds for cementum formation and integration on dentin surface

ABSTRACT

Purpose/Aim: Cementogenesis is a critical step in periodontal tissue regeneration given the essential role of cementum in anchoring teeth to the alveolar bone. This study is designed to achieve integrated cementum formation on the root surfaces of human teeth using growth factor–releasing scaffolds with periodontal ligament stem/progenitor cells (PDLSCs). Materials and methods: Human PDLSCs were sorted by CD146 expression, and characterized using CFU-F assay and induced multi-lineage differentiation. Polycaprolactone scaffolds were fabricated using 3D printing, embedded with poly(lactic-co-glycolic acids) (PLGA) microspheres encapsulating connective tissue growth factor (CTGF), bone morphogenetic protein-2 (BMP-2), or bone morphogenetic protein-7 (BMP-7). After removing cementum on human tooth roots, PDLSC-seeded scaffolds were placed on the exposed dentin surface. After 6-week culture with cementogenic/osteogenic medium, cementum formation and integration were evaluated by histomorphometric analysis, immunofluorescence, and qRT-PCR. Results: Periodontal ligament (PDL) cells sorted by CD146 and single-cell clones show a superior clonogenecity and multipotency as compared with heterogeneous populations. After 6 weeks, all the growth factor–delivered groups showed resurfacing of dentin with a newly formed cementum-like layer as compared with control. BMP-2 and BMP-7 showed de novo formation of tissue layers significantly thicker than all the other groups, whereas CTGF and BMP-7 resulted in significantly improved integration on the dentin surface. The de novo mineralized tissue layer seen in BMP-7-treated samples expressed cementum matrix protein 1 (CEMP1). Consistently, BMP-7 showed a significant increase in CEMP1 mRNA expression. Conclusion: Our findings represent important progress in stem cell–based cementum regeneration as an essential part of periodontium regeneration.     

Enhanced osteogenic activity of bone morphogenetic protein-2 by 2-O-desulfated heparin

The objective of this study was to investigate the effect of heparin sulfate groups on the osteogenic activity of bone morphogenetic protein-2 (BMP-2) in vitro and in vivo. Three types of desulfated (DS) derivatives of heparin (2-O-DS, 6-O-DS, and N-DS) were prepared and their bioactivity in rat bone marrow derived mesenchymal stem cells (MSC) in the absence or presence of BMP-2 was evaluated. When cultured with the 2-O-DS derivative and BMP-2 MSC showed enhanced proliferation, alkaline phosphatase activity, and Runx2 mRNA expression, compared with heparin and other derivatives. A similar tendency was observed for MSC cultured on two-dimensional substrates coated with heparin or the derivatives and in three-dimensional hydrogels containing heparin or the derivatives. A binding experiment demonstrated a greater binding affinity of 2-O-DS for BMP-2 than that of heparin and the other derivatives. Following implantation into the back subcutis of mice significantly greater ectopic bone formation in terms of bone weight, amount of calcium, and histology were observed for the gelatin hydrogels incorporating 2-O-DS and containing BMP-2. In addition, the gelatin hydrogels incorporating 2-O-DS showed controlled release of BMP-2 in vitro and in vivo. These findings demonstrated that the 2-O-DS derivative of heparin has a synergistic effect on the in vitro and in vivo osteogenic activity of BMP-2.     

中等强度运动对去卵巢大鼠骨质疏松及骨形态发生蛋白2信号通路的影响

目的 探讨中等强度运动对去卵巢大鼠骨密度、骨质代谢、骨生物力学及骨形态发生蛋白2(BMP-2)信号通路的影响。 方法 将24只成年雌性SD大鼠随机分为假手术组、手术组与运动组，每组8只，假手术组仅切除双侧卵巢周围脂肪组织，手术组、运动组摘除双侧卵巢，摘除卵巢1周后运动组进行中等强度运动训练，共训练12周。12周后，进行股骨骨密度、生物力学、骨代谢、组织学检测，Western blotting检测股骨组织BMP-2、Runt相关转录因子2（Runx2）、Osterix及Smad1/5/8蛋白表达。 结果 手术组、运动组血钙、血磷、血抗酒石酸酸性磷酸酶(TRACP)浓度高于假手术组(P<0.05)，而运动组上述指标低于手术组(P<0.05)。手术组和运动组骨密度低于假手术组(P<0.05)，而运动组高于手术组(P<0.05)。手术组和运动组骨组织生物力学性能低于假手术组(P<0.05)，而运动组高于手术组(P<0.05)。组织学显示，运动组骨质疏松程度轻于手术组，骨组织内BMP-2表达量多于手术组。手术组和运动组BMP-2、Runx2、Osterix及Smad1/5/8蛋白表达低于假手术组(P<0.05)，而运动组上述蛋白表达高于手术组(P<0.05)。 结论 中等强度运动可改善去卵巢大鼠股骨的骨密度、生物力学性能与骨代谢，这一作用可能与BMP-2信号通路有关。     

低载荷机械振动对去势大鼠骨组织成骨相关蛋白表达情况的影响

目的通过对去势大鼠加载不同时段的低载荷机械振动,探讨不同的振动持续时间对骨质疏松大鼠骨组织成骨相关蛋白表达的影响。方法 6个月龄雌性Wistar大鼠24只,随机分为8周去势对照组(C8)、12周去势对照组(C12)、8周振动组(V8)和12周振动组(V12)。所有大鼠接受去势手术1周后开始实施振动试验,对V8组与V12组大鼠分别加载35 Hz、0.25 g的低载荷机械振动,每天15 min;去势对照组不做处理。8周与12周后分两批断颈处死大鼠,采用Western blot技术检测各组大鼠成骨相关蛋白BMP-2、p-ERK、Runx2、OCN的表达。结果低载荷机械振动能够显著上调去势大鼠骨组织BMP-2、p-ERK、Runx2和OCN的蛋白表达水平(P<0.01),随着振动时间的延长,V12组较V8组蛋白含量分别增加了22.61%(P<0.05)、27.96%(P<0.01)、25.85%(P<0.01)、27.05%(P<0.01);去势对照组间各蛋白表达水平无明显差异(P>0.05)。结论低载荷机械振动能够上调骨组织成骨相关蛋白的表达水平,并随着振动时间的增加显现出更为优越的成骨作用。